$CTIC Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$CTIC Up to date company activities and other important information about $CTIC

$CTIC

DD Notes ~ http://www.ddnotesmaker.com/CTIC

##### recent news/filings ~ source: finance.yahoo.com

Tue, 01 Jul 2014 13:20:41 GMT ~ Tuesday’s Top Biotech Stories: CTI BioPharma, Agenus, and Salix Pharmaceuticals
read full: http://www.fool.com/investing/general/2014/07...lnk0000001
*********************************************************

Tue, 01 Jul 2014 10:05:20 GMT ~ CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis
- SEATTLE, July 1, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI or the Company) (NASDAQ and MTA: CTIC) announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of ...
read full: http://www.noodls.com/view/447D073B3AF8DF46C9...793AD50E76
*********************************************************

Tue, 01 Jul 2014 05:56:00 GMT ~ 1:56 am CTI BioPharma completes recruitment in PERSIST-1 pivotal Phase 3 trial of Pacritinib for patients with myelofibrosis; expects to receive $20 mln development milestone payment from Baxter (BAX)
read full: http://finance.yahoo.com/news/inplay-briefing....html#ctic
*********************************************************

Tue, 01 Jul 2014 05:30:00 GMT ~ CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis
- SEATTLE, July 1, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI or the Company) (NASDAQ and MTA: CTIC) announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis. Under the development and commercialization agreement for pacritinib with Baxter International, Inc. (Baxter), CTI expects to receive a $20 million development milestone payment in connection with the first treatment dosing of the last patient enrolled in PERSIST-1. CTI expects to achieve this milestone and receive payment by mid-third quarter 2014. "The PERSIST-1 clinical trial evaluating pacritinib, a novel JAK2/FLT3 inhibitor, is the most inclusive study of myelofibrosis patients seen in routine clinical practice to date," said Claire Harrison, M.D., Consultant Hematologist, Guy's and St. Thomas' NHS Foundation Trust, Guy's Hospital, London, United Kingdom and one of the principal investigators for PERSIST-1.
read full: http://finance.yahoo.com/news/cti-biopharma-c...00413.html
*********************************************************

Mon, 30 Jun 2014 20:54:58 GMT ~ CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan
read full: http://biz.yahoo.com/e/140630/ctic8-k.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=CTIC&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=CTIC&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CTIC/company-info
Ticker: $CTIC
OTC Market Place: Not Available
CIK code: 0000891293
Company name: CTI BioPharma Corp.
Company website: http://www.cticseattle.com
Incorporated In: WA, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CTIC/filings
Latest financials: http://www.otcmarkets.com/stock/CTIC/financials
Latest news: http://www.otcmarkets.com/stock/CTIC/news - http://finance.yahoo.com/q/h?s=CTIC+Headlines

Major holdings: http://data.cnbc.com/quotes/CTIC/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CTIC+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CTIC.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CTIC

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=CTI+BioPharma+Corp...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...harma+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cticseattle.com
Alexa: http://www.alexa.com/siteinfo/http://www.cticseattle.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cticseattle.com

Short Sales: http://www.otcmarkets.com/stock/CTIC/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/CTIC/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/CTIC/research
Historical Prices: http://finance.yahoo.com/q/hp?s=CTIC+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=CTIC+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=CTIC+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=CTIC+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=CTIC+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=CTIC+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=CTIC
Balance Sheet: http://finance.yahoo.com/q/bs?s=CTIC
Cash Flow: http://finance.yahoo.com/q/cf?s=CTIC+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/CTIC
Bloomberg: http://www.bloomberg.com/quote/CTIC:US
Morningstar: http://quotes.morningstar.com/stock/s?t=CTIC
Bussinessweek: http://investing.businessweek.com/research/st...icker=CTIC
Barchart: http://www.barchart.com/quotes/stocks/CTIC
OTC Short Report: http://otcshortreport.com/index.php?index=CTIC
Investopedia: http://www.investopedia.com/markets/stocks/CTIC/?wa=0

http://www.pennystocktweets.com/stocks/profile/CTIC

##### last known share structure ~ source: otcmarkets.com

Market Value: $421,022,657 a/o Jun 30, 2014
Shares Outstanding: 149,830,127 a/o Apr 23, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/CTIC

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 3

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 2

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock's Strong Performance Lifts Market Spirits

Updated Category News Views 62

BlackRock's Earnings Impact Future Market Trends As investors eagerly glance at the market, recent trends suggest a positive shift, particularly with BlackRock, Inc. reporting remarkable third-quarter earnings. The upbeat results have lifted not only the company’s profile but also the sentiments across various sectors. Market Overview In recent trading sessions, U.S....

Continue Reading
Endo Unveils I Got Somebody Campaign for Peyronie's Disease

Updated Category News Views 648

Endo Launches Awareness Campaign for Peyronie’s Disease Endo, Inc. (OTCQX: NDOI) has recently introduced a compelling initiative titled I Got Somebody. This campaign is designed to encourage men to confront their feelings of embarrassment around Peyronie's disease (PD) and to have open discussions about this condition which affects many. The company aims to empower men...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
SeaStar Medical Advances adult AKI Treatment with Stanford

Updated Category News Views 69

SeaStar Medical Welcomes Stanford Medicine's Enrollment in AKI Trial SeaStar Medical Holding Corporation (NASDAQ: ICU) is excited to announce that Stanford Medicine will begin actively enrolling subjects in its pivotal trial focused on Adult Acute Kidney Injury (AKI). This collaboration emphasizes the company’s mission to enhance treatment options for patients...

Continue Reading
Exciting Updates on Class A Shares for Investors and Stakeholders

Updated Category News Views 163

Important Distribution Announcement for Class A Shareholders In a recent announcement, Real Estate Split Corp. (TSX: RS) has excitedly shared plans to distribute dividends to Class A shareholders. This distribution not only signifies growth but also represents the company's commitment to providing value to its investors. Key Dates for the Upcoming Distribution For...

Continue Reading